Kalaris Therapeutics Inc
KLRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$58,769 | -$14,699 | -$15,485 | -$171,962 |
| Dep. & Amort. | $0 | $0 | $0 | $1,117 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $148 | $271 | $0 |
| Change in WC | -$25,305 | -$1,092 | $3,395 | $19,354 |
| Other Non-Cash | $16,369 | $1,511 | $2,040 | $45,172 |
| Operating Cash Flow | -$67,705 | -$14,132 | -$9,779 | -$106,319 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$26 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$76,591 |
| Inv. Sales/Matur. | $95,000 | $0 | $0 | $262,600 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $95,000 | $0 | $0 | $185,983 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $6,000 | $4,300 | $0 |
| Stock Issued | $21 | $0 | $0 | $232 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $8,242 | $8,480 | $0 |
| Financing Cash Flow | $21 | $14,242 | $12,780 | $232 |
| Forex Effect | $852 | $0 | $0 | -$896 |
| Net Chg. in Cash | $28,168 | $110 | $3,001 | $79,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $90,121 | $3,059 | $58 | $122,661 |
| End Cash | $118,289 | $3,169 | $3,059 | $201,661 |
| Free Cash Flow | -$67,705 | -$14,132 | -$9,779 | -$106,345 |